Ying Luo

Ying Luo

Ying’s Company

Rigel Pharmaceuticals

Funding: $130M

Website: http://www.rigel.com

Rigel Pharmaceuticals, Inc. (Rigel), incorporated in June 1996, is a clinical-stage drug development company. The Company discovers and develops ... More » Rigel Pharmaceuticals, Inc. (Rigel), incorporated in June 1996, is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. The Company has product development programs in inflammatory/autoimmune diseases, such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer. [ CrunchBase ]

Bina Technologies Expands Scientific Advisory

Rigel - In addition to existing SAB members Dr. Wing Wong, a professor of Statistics and of Health Research and Policy at Stanford University; Dr. Garry Nolan, Professor of Microbiology and Immunology at the Stanford School of Medicine and co-founder of several biotechnology companies including ...

Garry Nolan

Mentioned in this article:
Garry Nolan

Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye

Rigel - "Our ophthalmic formulation of R348 was shown to be well tolerated in our recent Phase 1 study and we look forward to evaluating the drug candidate in patients with chronic dry eye disorders," said Raul Rodriguez, president and chief operating officer of Rigel. "In addition, for our two ...

Raul Rodriguez

Mentioned in this article:
Raul Rodriguez

Rigel to cut 30 jobs, focus on three drug programs - San Francisco Business Times

Rigel to cut 30 jobs, focus on three drug programs Happier days: Rigel co-founder Donald Payan and President Raul Rodriguez, before AstraZeneca returned the once-promising drug fostamatinib and an asthma drug failed a Phase II trial. The company said Thursday that it will lay off 30 ...

Raul Rodriguez

Mentioned in this article:
Raul Rodriguez

Rigel Announces Participation at Two Investor Conferences - Yahoo! Finance

Rigel - Thu, Feb 28, 2013, 7:49 AM EST - U.S. Markets open in 1 hr 41 mins SOUTH SAN FRANCISCO, Calif., Feb. 28, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ( RIGL ) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and ...

Ryan Maynard

Mentioned in this article:
Ryan Maynard

Disappointments, New Prospects for Rigel Pharmaceuticals | Xconomy

That cash cushion gives Rigel time to test its stable of experimental drugs against three less common autoimmune disorders, in smaller, less expensive trials that it can fund independently, says chief operating officer Raul Rodriguez. “We’re in a good financial position to decide where ...

Join Newsle to find out when Ying Luo makes the news.

As a Newsle member, you’ll be able to:

  • Get alerts on Ying Luo
  • See news articles & blog posts about Ying Luo
  • Follow your friends & colleagues in the news
This profile only includes publicly available information. Questions or comments? Contact Us
Freebase CC-BY
Data from Freebase, licensed under CC-BY
Source: CrunchBase
Data from Wikipedia, licensed under the GFDL